• YC-1: HIF-1α Signaling and Assay Design

  2026-09-10

  YC-1 is more than a hypoxia-pathway reagent: it can function as a pharmacological causal probe when paired with orthogonal molecular and phenotypic readouts. This article interprets a recent hippocampal HIF-1α study and translates its logic into rigorous cancer, vascular, and apoptosis assay design.

• ECL Chemiluminescent Substrate Detection Kit Workflow

  2026-09-10

  Build a sensitive, reproducible immunoblot workflow for scarce targets using HRP-mediated chemiluminescence, membrane-specific optimization, and extended imaging windows. The approach also shows how immunoblotting can complement the urine nanosensor strategy reported for early atherosclerosis research.

• Isochlorogenic Acid A: From Molecule to Translation

  2026-09-09

  Isochlorogenic acid A, also known as 3,5-Dicaffeoylquinic acid, is moving from natural-product characterization toward formulation-enabled wound-repair research. This evidence-led perspective connects molecular identity, assay design, hydrogel engineering, and translational decision-making while keeping preclinical findings separate from clinical claims.

• RP3-340N1.2, IL-6, and NSCLC Progression

  2026-09-09

  This study identifies the lncRNA RP3-340N1.2 as a regulator of IL-6 mRNA stability in non-small cell lung cancer. Its knockdown enhances ZC3H12A-dependent IL-6 mRNA degradation, reducing tumor-cell proliferation, migration, and tumor-associated macrophage polarization.

• Grx2, HNRNPA2B1, and Ferroptosis in Diabetic Cataract

  2026-09-08

  The reference study identifies a redox-regulatory mechanism in which glutaredoxin 2 protects lens epithelial cells from high-glucose-induced ferroptosis by limiting HNRNPA2B1 S-glutathionylation and downstream PTEN/AKT disruption. Its combination of LC-MS/MS, co-immunoprecipitation, lentiviral perturbation, and orthogonal redox and cell-death assays provides a framework for connecting protein thiol modification with diabetes-mediated cataractogenesis.

• LY2109761 Workflow for TGF-β Signaling Studies

  2026-09-08

  Build reproducible TGF-β pathway assays with LY2109761, from DMSO handling and Smad2/3 readouts to migration, fibrosis, and radiosensitivity models. The workflow also shows how to distinguish direct receptor blockade from downstream effects highlighted in recent pancreatic cancer research.

• GR Control of Brain CYPs in Phenytoin Neurotoxicity

  2026-09-07

  Nkosi and Maseko report that pregnenolone 16α-carbonitrile suppresses hippocampal CYP expression and reduces phenytoin-associated neuronal injury through glucocorticoid receptor signaling rather than the expected PXR pathway. The work highlights tissue-specific nuclear-receptor pharmacology and provides a framework for separating hepatic enzyme induction from brain-specific drug responses.

• RHEB Neddylation Links UBE2F to Liver Tumorigenesis

  2026-09-07

  The reference study identifies RHEB as a non-cullin substrate of the UBE2F-SAG neddylation machinery and maps the modification to lysine 169. By connecting RHEB neddylation with lysosomal localization, GTP loading, mTORC1 activation, and liver tumorigenesis, the work provides a mechanistic explanation for how aberrant neddylation can intensify PTEN-loss-associated liver disease.

• Selective Autophagy Tunes IRF3 Stability and IFN

  2026-09-05

  Wu and colleagues show that CALCOCO2/NDP52-mediated selective autophagy degrades IRF3 in a virus load-dependent manner, while PSMD14 preserves IRF3 by removing K27-linked ubiquitin chains at lysine 313. The work defines a regulatory axis that balances type I interferon production with immune suppression and provides a framework for studying transcription-factor stability during antiviral signaling.

• Ertapenem in Translational Resistance Research

  2026-09-04

  A mechanistic and translational framework for using Ertapenem sodium salt to connect PBP biology, phenotype testing, carbapenemase transmission, and resistance research strategy.

• X-press Tag Peptide for Reliable Protein Assays

  2026-09-04

  This scenario-driven guide explains how X-press Tag Peptide (SKU A6010) can strengthen recombinant-protein preparation for cell viability, proliferation, and cytotoxicity studies. It connects documented composition, solubility, affinity options, and storage requirements with practical controls for interpreting biology-driven assay changes.

• WNT5a/GSK3/β-Catenin Control of Muscle FAPs

  2026-09-03

  This study identifies the WNT5a/GSK3/β-catenin axis as a previously underappreciated regulator of adipogenic differentiation in skeletal muscle fibro/adipogenic progenitors. By integrating pharmacological screening, mass cytometry, network modeling, and transcriptomic datasets, the authors connect β-catenin stabilization with reduced fat accumulation and improved FAP support of muscle regeneration.

• Panobinostat (LBH589): Reliable Cell Assays

  2026-09-03

  This scenario-based guide explains how Panobinostat (LBH589), SKU A8178, can support more interpretable viability, proliferation, and apoptosis experiments. It combines product-specific handling data with current evidence on HDAC biology and RNA polymerase II-linked cell death signaling.

• BML-277: Mapping the Chk2–cGAS Checkpoint

  2026-09-02

  BML-277 is a potent Chk2 inhibitor for dissecting DNA damage signaling beyond simple kinase readouts. This article explains how to use it to test the CHK2–cGAS–TRIM41 pathway while separating biochemical inhibition, T-cell radioprotection, and L1 retrotransposition phenotypes.

• Tin Mesoporphyrin IX: HO Assay Strategy

  2026-09-02

  Tin Mesoporphyrin IX (chloride) is a nanomolar competitive heme oxygenase inhibitor for mechanistic studies of heme catabolism, redox biology, and metabolic disease research. This article shows how to use C5606 to distinguish HO-dependent effects from downstream antiviral and cellular phenotypes.

582 records 7/39 page Previous Next First page 上5页 678910 下5页 Last page